 |
Previous Article | Next Article 
The Journal of Neuroscience, December 1, 1998, 18(23):9790-9799
Overexpression in Neurons of Human Presenilin-1 or a Presenilin-1
Familial Alzheimer Disease Mutant Does Not Enhance Apoptosis
Sherry
Bursztajn1,
Richard
DeSouza2,
Donna L.
McPhie3,
S. A.
Berman1,
Junichi
Shioi4,
Nikolaos K.
Robakis4, and
Rachael L.
Neve3
1 Department of Psychiatry and Program in Neuroscience,
Harvard Medical School, Belmont, Massachusetts 02478, 2 Department of Biology, Massachusetts Institute of
Technology, Cambridge, Massachusetts 02139, 3 Department of
Genetics, Harvard Medical School, McLean Hospital, Belmont,
Massachusetts 02478, and 4 Department of Psychiatry and
Fishberg Research Center for Neurobiology, Mount Sinai School of
Medicine, New York, New York 10029
Programmed cell death, or apoptosis, has been implicated in
Alzheimer's disease (AD). DNA damage was assessed in primary cortical neurons infected with herpes simplex virus (HSV) vectors expressing the
familial Alzheimer's disease (FAD) gene presenilin-1 (PS-1) or an FAD
mutant of this gene, A246E. After infection, immunoreactivity for PS-1
was shown to be enhanced in infected cells. The infected cells
exhibited no cytotoxicity, as evaluated by trypan blue exclusion and
mitochondrial function assays. Quantitative analysis of cells that were
immunohistochemically labeled using a Klenow DNA fragmentation assay or
the TUNEL method revealed no enhancement of apoptosis in PS-1-infected
cells. This result was confirmed using assays for chromatin
condensation and for DNA fragmentation. Expression of PS-1 protected
against induction of apoptosis in the cortical neurons by etoposide or
staurosporine. The specificity of this phenotype was demonstrated by
the fact that cortical cultures infected with recombinant HSV vectors
expressing the amyloid precursor protein (APP-695) showed, in contrast,
a significant increase in the number of apoptotic cells and an increase
in DNA fragmentation for all parameters tested. Our results indicate
that overexpression of wild-type or A246E mutant PS-1 does not enhance
apoptosis in postmitotic cortical cells and suggest that the previously
reported enhancement of apoptosis by presenilins may be dependent on
cell type.
Key words:
apoptosis; neurodegeneration; presenilin; amyloid
precursor protein; DNA fragmentation; Alzheimer's disease
Copyright © 1998 Society for Neuroscience 0270-6474/98/18239790-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. Laifenfeld, L. J. Patzek, D. L. McPhie, Y. Chen, Y. Levites, A. M. Cataldo, and R. L. Neve
Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis
J. Neurosci.,
July 4, 2007;
27(27):
7141 - 7153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dunys, T. Kawarai, J. Sevalle, V. Dolcini, P. St. George-Hyslop, C. A. Da Costa, and F. Checler
p53-dependent Aph-1 and Pen-2 Anti-apoptotic Phenotype Requires the Integrity of the {gamma}-Secretase Complex but Is Independent of Its Activity
J. Biol. Chem.,
April 6, 2007;
282(14):
10516 - 10525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cai, P. Lin, K.-H. Cheung, N. Li, C. Levchook, Z. Pan, C. Ferrante, G. L. Boulianne, J. K. Foskett, D. Danielpour, et al.
The Presenilin-2 Loop Peptide Perturbs Intracellular Ca2+ Homeostasis and Accelerates Apoptosis
J. Biol. Chem.,
June 16, 2006;
281(24):
16649 - 16655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alves da Costa, C. Sunyach, R. Pardossi-Piquard, J. Sevalle, B. Vincent, N. Boyer, T. Kawarai, N. Girardot, P. St. George-Hyslop, and F. Checler
Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease.
J. Neurosci.,
June 7, 2006;
26(23):
6377 - 6385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. McPhie, R. Coopersmith, A. Hines-Peralta, Y. Chen, K. J. Ivins, S. P. Manly, M. R. Kozlowski, K. A. Neve, and R. L. Neve
DNA Synthesis and Neuronal Apoptosis Caused by Familial Alzheimer Disease Mutants of the Amyloid Precursor Protein Are Mediated by the p21 Activated Kinase PAK3
J. Neurosci.,
July 30, 2003;
23(17):
6914 - 6927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. da Costa, M. P. Mattson, K. Ancolio, and F. Checler
The C-terminal Fragment of Presenilin 2 Triggers p53-mediated Staurosporine-induced Apoptosis, a Function Independent of the Presenilinase-derived N-terminal Counterpart
J. Biol. Chem.,
March 28, 2003;
278(14):
12064 - 12069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xu, Y.-c. Shi, W. Gao, G. Mao, G. Zhao, S. Agrawal, G. M. Chisolm, D. Sui, and M.-Z. Cui
The Novel Presenilin-1-associated Protein Is a Proapoptotic Mitochondrial Protein
J. Biol. Chem.,
December 6, 2002;
277(50):
48913 - 48922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev.,
September 1, 2002;
54(3):
469 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mbebi, V. See, L. Mercken, L. Pradier, U. Muller, and J.-P. Loeffler
Amyloid Precursor Protein Family-induced Neuronal Death Is Mediated by Impairment of the Neuroprotective Calcium/Calmodulin Protein Kinase IV-dependent Signaling Pathway
J. Biol. Chem.,
May 31, 2002;
277(23):
20979 - 20990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alves da Costa, E. Paitel, M. P. Mattson, R. Amson, A. Telerman, K. Ancolio, and F. Checler
Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons
PNAS,
March 19, 2002;
99(6):
4043 - 4048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Siman, A. G. Reaume, M. J. Savage, S. Trusko, Y.-G. Lin, R. W. Scott, and D. G. Flood
Presenilin-1 P264L Knock-In Mutation: Differential Effects on Abeta Production, Amyloid Deposition, and Neuronal Vulnerability
J. Neurosci.,
December 1, 2000;
20(23):
8717 - 8726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Grilli, E. Diodato, G. Lozza, R. Brusa, M. Casarini, D. Uberti, R. Rozmahel, D. Westaway, P. St George-Hyslop, M. Memo, et al.
Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically
PNAS,
November 7, 2000;
97(23):
12822 - 12827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, D. L. McPhie, J. Hirschberg, and R. L. Neve
The Amyloid Precursor Protein-binding Protein APP-BP1 Drives the Cell Cycle through the S-M Checkpoint and Causes Apoptosis in Neurons
J. Biol. Chem.,
March 17, 2000;
275(12):
8929 - 8935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ye and M. E. Fortini
Apoptotic Activities of Wild-Type and Alzheimer's Disease-Related Mutant Presenilins in Drosophila melanogaster
J. Cell Biol.,
September 20, 1999;
146(6):
1351 - 1364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uetsuki, K. Takemoto, I. Nishimura, M. Okamoto, M. Niinobe, T. Momoi, M. Miura, and K. Yoshikawa
Activation of Neuronal Caspase-3 by Intracellular Accumulation of Wild-Type Alzheimer Amyloid Precursor Protein
J. Neurosci.,
August 15, 1999;
19(16):
6955 - 6964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Weihl, G. D. Ghadge, S. G. Kennedy, N. Hay, R. J. Miller, and R. P. Roos
Mutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB
J. Neurosci.,
July 1, 1999;
19(13):
5360 - 5369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimoto, T. Niikura, Y. Ito, and I. Nishimoto
Multiple Mechanisms Underlie Neurotoxicity by Different Types of Alzheimer's Disease Mutations of Amyloid Precursor Protein
J. Biol. Chem.,
October 27, 2000;
275(44):
34541 - 34551.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|